97 related articles for article (PubMed ID: 34542089)
41. Clinical management of abnormal Pap tests: differences between US and Korean guidelines.
Won S; Kim MK; Seong SJ
J Pathol Transl Med; 2020 May; 54(3):213-219. PubMed ID: 32460475
[TBL] [Abstract][Full Text] [Related]
42. ASCCP Colposcopy Standards: Risk-Based Colposcopy Practice.
Wentzensen N; Schiffman M; Silver MI; Khan MJ; Perkins RB; Smith KM; Gage JC; Gold MA; Conageski C; Einstein MH; Mayeaux EJ; Waxman AG; Huh WK; Massad LS
J Low Genit Tract Dis; 2017 Oct; 21(4):230-234. PubMed ID: 28953111
[TBL] [Abstract][Full Text] [Related]
43. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP).
Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE
Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488
[TBL] [Abstract][Full Text] [Related]
44. Management of women with cervical cytologic results interpreted as low-grade squamous intraepithelial lesion: the foundation of the ASCCP guidelines.
Spitzer M; Wilkinson EJ; Ferris D; Waxman AG; Hatch KD; Werner C; Bibbo M; Colgan TJ; Cornelison T; Partridge EE
J Low Genit Tract Dis; 2003 Oct; 7(4):241-9. PubMed ID: 17051078
[No Abstract] [Full Text] [Related]
45. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.
Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
Radiother Oncol; 2018 Jun; 127(3):404-416. PubMed ID: 29728273
[TBL] [Abstract][Full Text] [Related]
46. [Epidemiology, prevention and early detection of cervical cancer].
Wentzensen N
Onkologe (Berl); 2016 Oct; 22(10):725-736. PubMed ID: 28265177
[TBL] [Abstract][Full Text] [Related]
47. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.
Cibula D; Pötter R; Planchamp F; Avall-Lundqvist E; Fischerova D; Haie-Meder C; Köhler C; Landoni F; Lax S; Lindegaard JC; Mahantshetty U; Mathevet P; McCluggage WG; McCormack M; Naik R; Nout R; Pignata S; Ponce J; Querleu D; Raspagliesi F; Rodolakis A; Tamussino K; Wimberger P; Raspollini MR
Virchows Arch; 2018 Jun; 472(6):919-936. PubMed ID: 29725757
[TBL] [Abstract][Full Text] [Related]
48. Advanced Technologies in Cervical Cancer Screening ASCCP Biennial Meeting 1998.
Cox JT; Herbst AL; Kinney W; Lorincz AT; Richart RM; Schiffman MH
J Low Genit Tract Dis; 1999 Jan; 3(1 Suppl):S8. PubMed ID: 25950436
[No Abstract] [Full Text] [Related]
49. Belgian consensus guidelines for follow-up of women with cervical cytological abnormalities.
Cuvelier CA; Bogers JP; Bourgain C; Delvenne P; Drijkoningen M; Garbar C; Kevers M; Remmelinck M; Thienpont L; Verhest A; Weynand B; Willocx F
Acta Clin Belg; 2009; 64(2):136-43. PubMed ID: 19432026
[TBL] [Abstract][Full Text] [Related]
50. Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology.
Barroeta JE; Adhikari-Guragain D; Grotkowski CE
Diagn Cytopathol; 2017 Oct; 45(10):903-914. PubMed ID: 28589649
[TBL] [Abstract][Full Text] [Related]
51. What women want. Women's preferences for the management of low-grade abnormal cervical screening tests: a systematic review.
Frederiksen ME; Lynge E; Rebolj M
BJOG; 2012 Jan; 119(1):7-19. PubMed ID: 21895959
[TBL] [Abstract][Full Text] [Related]
52. Importance of HPV Genotyping for the Screening, Therapy and Management of Cervical Neoplasias.
Jentschke M; Soergel P; Hillemanns P
Geburtshilfe Frauenheilkd; 2012 Jun; 72(6):507-512. PubMed ID: 25374431
[TBL] [Abstract][Full Text] [Related]
53. ACOG Committee Opinion No. 463: Cervical cancer in adolescents: screening, evaluation, and management.
Obstet Gynecol; 2010 Aug; 116(2 Pt 1):469-472. PubMed ID: 20664421
[TBL] [Abstract][Full Text] [Related]
54. The influence of ASCCP guideline changes on family medicine residency colposcopy training.
Keehbauch J; Green L; Lugo N; Pepe J
Fam Med; 2012 Oct; 44(9):650-3. PubMed ID: 23027158
[TBL] [Abstract][Full Text] [Related]
55. Role of Screening History in Clinical Meaning and Optimal Management of Positive Cervical Screening Results.
Castle PE; Kinney WK; Xue X; Cheung LC; Gage JC; Poitras NE; Lorey TS; Katki HA; Wentzensen N; Schiffman M
J Natl Cancer Inst; 2019 Aug; 111(8):820-827. PubMed ID: 30576462
[TBL] [Abstract][Full Text] [Related]
56. Erratum to '2022 ISFM Consensus Guidelines on Management of the Inappetent Hospitalised Cat'.
J Feline Med Surg; 2023 Feb; 25(2):1098612X221149867. PubMed ID: 36779793
[No Abstract] [Full Text] [Related]
57. 2021 ASCCP Oral Presentations.
J Low Genit Tract Dis; 2021 Apr; 25(2S):1-8. PubMed ID: 33743522
[No Abstract] [Full Text] [Related]
58. 2019 ASCCP Oral Presentations.
J Low Genit Tract Dis; 2019 Apr; 23(2S Suppl 1):S1-S10. PubMed ID: 30889031
[No Abstract] [Full Text] [Related]
59. 2022 ASCCP Oral Presentations.
J Low Genit Tract Dis; 2022 Apr; 26(2S):1-5. PubMed ID: 35350042
[No Abstract] [Full Text] [Related]
60. 2023 ASCCP Oral Presentations.
J Low Genit Tract Dis; 2023 Jul; 27(3S Suppl 1):S1-S7. PubMed ID: 37145995
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
